Ifp Advisors, Inc Neogenomics Inc Transaction History

Ifp Advisors, Inc

$3.07 Billion
Q1 2025

A detailed history of Ifp Advisors, Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 9 shares of NEO stock, worth $64. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 9 -0.0%

Holding current value

$64

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$13.0 - $18.43 $117 - $165	9 New	9 $0
Q4 2022 Feb 07, 2023	BUY	$6.45 - $12.07 $58 - $108	9 New	9 $5,000
Q1 2022 Aug 08, 2022	BUY	$12.15 - $35.28 $595 - $1,728	49 Added 20.76%	285 $3,000
Q4 2021 Jan 12, 2022	BUY	$30.49 - $48.49 $1,097 - $1,745	36 Added 18.0%	236 $8,000
Q3 2021 Oct 06, 2021	SELL	$41.66 - $52.52 $4,499 - $5,672	-108 Reduced 35.06%	200 $10,000
Q2 2021 Jul 13, 2021	SELL	$36.62 - $51.69 $104,769 - $147,885	-2,861 Reduced 90.28%	308 $14,000
Q4 2020 Jan 25, 2021	BUY	$36.08 - $56.47 $85,942 - $134,511	2,382 Added 302.67%	3,169 $170,000
Q3 2020 Oct 29, 2020	BUY	$33.26 - $40.48 $2,893 - $3,521	87 Added 12.43%	787 $28,000
Q1 2020 May 12, 2020	BUY	$20.5 - $34.53 $10,250 - $17,265	500 Added 250.0%	700 $19,000
Q3 2019 Nov 07, 2019	BUY	$19.12 - $26.24 $3,824 - $5,248	200 New	200 $4,000
Q1 2019 May 15, 2019	SELL	$12.14 - $20.46 $230 - $388	-19 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$12.5 - $15.38 $237 - $292	19 New	19 $0
Q4 2017 Jan 24, 2018	SELL	$8.02 - $11.18 $24,060 - $33,540	-3,000 Closed	0 $0
Q4 2016 Jun 03, 2019	SELL	N/A	-2,500 Reduced 45.45%	3,000 $26,000
Q2 2016 Jun 03, 2019	BUY	N/A	5,500	5,500 $44,000

Others Institutions Holding NEO

# of Institutions

288

Shares Held

127M

Call Options Held

942K

Put Options Held

172K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $897M
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account